Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Nodule 2 Pain 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Agnosia 2 Prostatic Neoplasms 1 Neuroma 1 Neuralgia 1 Neoplasm Metastasis 1 Myoma 1 Multiple Pulmonary Nodules 1 Multiple Advanced Tumors After PD-1 Therapy Failure 1 Menorrhagia 1 Lymphoma, Follicular 1 Lipoma 1 Leiomyoma 1 Hypesthesia 1 Hyperthyroidism 1 Hyperaldosteronism 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cicatrix 1 Carcinoma, Renal Cell 1 Breast Cancer Female 1 Bone Cancer Metastatic 1 Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1 ACTH Syndrome, Ectopic 1

Interventions

Uterine Myomectomy 2 relugolix 1 elagolix 1 Uterine Artery Embolization 1 Radiofrequency Ablation 1 Norethindrone Acetate 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Menorrhagia × Radiofrequency Ablation × 1 year × Clear all

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡